Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements

• Robert J. Kimmerling,
• Mark M. Stevens,
• Selim Olcum,
• Anthony Minnah,
• Madeleine Vacha,
• Rachel LaBella,
• Matthew Ferri,
• Steven C. Wasserman,
• Juanita Fujii,
• Zayna Shaheen,
• Srividya Sundaresan,
• Drew Ribadeneyra,
• David S. Jayabalan,
• Sarita Agte,
• Adolfo Aleman,
• Joseph A. Criscitiello,
• Ruben Niesvizky,
• Marlise R. Luskin,
• Samir Parekh,
• Cara A. Rosenbaum,
• Anobel Tamrazi,
• Clifford A. Reid

Affiliations

Robert J. Kimmerling

Travera

Mark M. Stevens

Travera

Selim Olcum

Travera

Anthony Minnah

Travera

Madeleine Vacha

Travera

Rachel LaBella

Travera

Matthew Ferri

Travera

Steven C. Wasserman

Travera

Juanita Fujii

Department of Clinical Research, Dignity Health, Sequoia Hospital

Zayna Shaheen

Department of Clinical Research, Dignity Health, Sequoia Hospital

Srividya Sundaresan

Department of Clinical Research, Dignity Health, Sequoia Hospital

Drew Ribadeneyra

Weill Cornell Medicine

David S. Jayabalan

Weill Cornell Medicine

Sarita Agte

Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai

Adolfo Aleman

Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai

Joseph A. Criscitiello

Department of Medical Oncology, Dana-Farber Cancer Institute

Ruben Niesvizky

Weill Cornell Medicine

Marlise R. Luskin

Department of Medical Oncology, Dana-Farber Cancer Institute

Samir Parekh

Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai

Cara A. Rosenbaum

Weill Cornell Medicine

Anobel Tamrazi

Division of Vascular and Interventional Radiology, Palo Alto Medical Foundation

Clifford A. Reid

Travera